STOCK TITAN

CN Healthy Food Tech gets new delisting determination

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

CN Healthy Food Tech Group Corp. (UCFI) disclosed that Nasdaq issued an additional delisting determination for its common stock and warrants on November 9, 2026. Trading in both securities remains halted. The Nasdaq Hearings Panel will consider the matter as part of its decision on the company’s continued listing on the Nasdaq Capital Market.

The Panel had allowed continued listing subject to conditions in an October 7, 2026 decision. Trading was scheduled to resume on October 19, 2026, but Nasdaq continued the halt while seeking further information. The company may provide additional information to the Panel by November 16, 2026, and intends to present its views by then. The company said there is no assurance that the Panel will rule in its favor or that trading will resume or the securities will remain listed.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • None.

Negative

  • Major pointNovember 9, 2026: additional delisting determination applies to both securities.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Additional delisting determination November 9, 2026 Nasdaq issued an additional delisting determination for the common stock and warrants.
Panel decision October 7, 2026 The Panel allowed continued listing subject to conditions.
Scheduled trading resumption October 19, 2026 Trading was scheduled to resume, but the halt continued while Nasdaq sought further information.
Response deadline November 16, 2026 The company may provide additional information to the Panel by this date.
Warrant exercise price $11.50 per share Each whole warrant is exercisable for one share of common stock.
additional delisting determination regulatory
"Nasdaq issued an additional delisting determination"
trading halt regulatory
"The trading halt in the Listed Securities remains in effect"
A trading halt is a temporary pause on buying and selling a particular stock imposed by an exchange or regulator, like pressing the pause button on a game so everyone can catch up. It is used to give the market time to absorb important new information or to prevent chaotic price swings, and matters to investors because it freezes the ability to trade, delays price discovery, and can change risk and strategy until normal trading resumes.
continued listing regulatory
"the Panel in its decision regarding the Company’s continued listing"
When a stock receives a "continued listing," it means the exchange has decided the company’s shares will remain tradable on that market after a review or challenge, often because the company met certain requirements or corrective steps. For investors this matters because continued listing preserves liquidity and access to buy or sell the stock—think of it as a store passing an inspection so customers can keep shopping rather than being forced to close.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Is UCFI trading again?

No. The trading halt remains in effect for CN Healthy Food Tech Group Corp.’s common stock and warrants. Trading had been scheduled to resume on October 19, 2026, but Nasdaq continued the halt while seeking further information.

What is the deadline for UCFI to respond to the Nasdaq Panel?

The company may provide additional information to the Nasdaq Hearings Panel by November 16, 2026, and intends to present its views by that deadline. The Panel will consider the matter in deciding the company’s continued listing on the Nasdaq Capital Market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001901203 0001901203 2026-11-09 2026-11-09 0001901203 UCFI:CommonStockParValue0.0001PerShareMember 2026-11-09 2026-11-09 0001901203 UCFI:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2026-11-09 2026-11-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) November 9, 2026

 

CN Healthy Food Tech Group Corp.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41898   85-4105289
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

Fuhuali Zhonghai Plaza, Building B, Suite 1001

2021 West Jiuzhou Blvd., Xiangzhou District

Zhuhai City, Guangdong Province, China 519000

(Address, including zip code, of principal executive offices)

 

+(86) 0756-8300081

Registrant’s telephone number, including area code

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.0001 per share   UCFI   The Nasdaq Stock Market
Warrants, each whole warrant exercisable for one share of Common stock at an exercise price of $11.50 per share   UCFIW   The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

As previously disclosed, on July 16, 2026, CN Healthy Food Tech Group Corp. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (the “Nasdaq”) stating that the Staff had determined to delist the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (the “Warrant,” together with the Common Stock, the “Listed Securities”), based on Nasdaq Listing Rule 5101 and IM-5101-1 (together, “Rule 5101”) and the Company’s alleged violation of Nasdaq Listing Rules 5205(e) and 5250(a)(1) (the “Misrepresentation Rules”). The Company appealed, and by letter dated October 7, 2026, the Nasdaq Hearings Panel (the “Panel”) determined to allow the Company to maintain its listing subject to certain conditions. Trading in the Common Stock was scheduled to resume on October 19, 2026; however, after receiving additional information from the China Securities Regulatory Commission (the “CSRC”), the Staff continued the trading halt to request additional information from the Company.

 

On November 9, 2026, the Company received a letter (the “Determination Letter”) from Nasdaq whereby the Staff determined to issue an additional delisting determination pursuant to Rule 5101 and for violation of the Misrepresentation Rules, based on information received from the CSRC, including a letter from the CSRC to the Staff dated October 30, 2026, which serves as an additional basis for delisting the Listed Securities. The Determination Letter states that the CSRC made certain allegations regarding, among other things, the status of the Company’s compliance with CSRC filing requirements, the authenticity of certain materials the Company previously provided to the Staff, the Company’s responsiveness to CSRC inquiries, and the Company’s PRC counsel.

 

The Panel will consider this matter in its decision regarding the Company’s continued listing on The Nasdaq Capital Market. The Company may provide more information to address this additional deficiency to the Panel in writing no later than November 16, 2026. The Company intends to present its views to the Panel by that deadline. The trading halt in the Listed Securities remains in effect. There can be no assurance that the Panel will rule in the Company’s favor, or that the Listed Securities will resume trading or continue to be listed on Nasdaq.

 

Forward-Looking Statements

 

Certain statements made in this Current Report on Form 8-K are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the “safe harbor” provisions under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this Current Report on Form 8-K are forward-looking statements. When used in this Current Report on Form 8-K, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and variations of these words or similar expressions (or the negative versions of such words or expressions), as they relate to the Company or its management team, are intended to identify forward-looking statements. Many factors could cause actual future events to differ materially from the forward-looking statements in this Current Report on Form 8-K, including the Company’s ability to successfully address the Staff’s additional delisting determination before the Panel and the risks associated with delisting of the Company’s securities from Nasdaq. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of the Company, including those set forth in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K, and other reports and registration statements of the Company filed, or to be filed, with the SEC, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. All subsequent written or oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety by this paragraph. The Company undertakes no obligation to update or revise any forward-looking statements for revisions or changes after the date of this Current Report on Form 8-K, except as required by law.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CN HEALTHY FOOD TECH GROUP CORP.
     
Date: November 13, 2026 By: /s/ Zhenjun Jiang
  Name: Zhenjun Jiang
  Title: Chief Executive Officer and Chairman of the Board

 

2

 

Filing Exhibits & Attachments

4 documents

Keep reading